121 related articles for article (PubMed ID: 18823279)
61. The lignan niranthin poisons Leishmania donovani topoisomerase IB and favours a Th1 immune response in mice.
Chowdhury S; Mukherjee T; Mukhopadhyay R; Mukherjee B; Sengupta S; Chattopadhyay S; Jaisankar P; Roy S; Majumder HK
EMBO Mol Med; 2012 Oct; 4(10):1126-43. PubMed ID: 23027614
[TBL] [Abstract][Full Text] [Related]
62. Characterization of the DNA-binding domain and identification of the active site residue in the 'Gyr A' half of Leishmania donovani topoisomerase II.
Sengupta T; Mukherjee M; Das R; Das A; Majumder HK
Nucleic Acids Res; 2005; 33(8):2364-73. PubMed ID: 15860773
[TBL] [Abstract][Full Text] [Related]
63. Selective antimicrotubule activity of N1-phenyl-3,5-dinitro-N4,N4-di-n-propylsulfanilamide (GB-II-5) against kinetoplastid parasites.
Werbovetz KA; Sackett DL; Delfín D; Bhattacharya G; Salem M; Obrzut T; Rattendi D; Bacchi C
Mol Pharmacol; 2003 Dec; 64(6):1325-33. PubMed ID: 14645662
[TBL] [Abstract][Full Text] [Related]
64. Identification of potent inhibitors for
Soni M; Srivastava G; Ramalingam K; Shakya AK; Siddiqi MI; Pratap JV
J Biomol Struct Dyn; 2023 Nov; ():1-16. PubMed ID: 37962849
[TBL] [Abstract][Full Text] [Related]
65. Disuccinyl betulin triggers metacaspase-dependent endonuclease G-mediated cell death in unicellular protozoan parasite Leishmania donovani.
Chowdhury S; Mukherjee T; Chowdhury SR; Sengupta S; Mukhopadhyay S; Jaisankar P; Majumder HK
Antimicrob Agents Chemother; 2014; 58(4):2186-201. PubMed ID: 24468787
[TBL] [Abstract][Full Text] [Related]
66. Chemical Validation of Methionyl-tRNA Synthetase as a Druggable Target in Leishmania donovani.
Torrie LS; Brand S; Robinson DA; Ko EJ; Stojanovski L; Simeons FRC; Wyllie S; Thomas J; Ellis L; Osuna-Cabello M; Epemolu O; Nühs A; Riley J; MacLean L; Manthri S; Read KD; Gilbert IH; Fairlamb AH; De Rycker M
ACS Infect Dis; 2017 Oct; 3(10):718-727. PubMed ID: 28967262
[TBL] [Abstract][Full Text] [Related]
67. Novel betulin derivatives as antileishmanial agents with mode of action targeting type IB DNA topoisomerase.
Chowdhury S; Mukherjee T; Sengupta S; Chowdhury SR; Mukhopadhyay S; Majumder HK
Mol Pharmacol; 2011 Oct; 80(4):694-703. PubMed ID: 21750153
[TBL] [Abstract][Full Text] [Related]
68. Proteomic Analysis of
Verma S; Deep DK; Gautam P; Singh R; Salotra P
Pathogens; 2021 Sep; 10(9):. PubMed ID: 34578226
[TBL] [Abstract][Full Text] [Related]
69. Curcumin overcomes the inhibitory effect of nitric oxide on Leishmania.
Chan MM; Adapala NS; Fong D
Parasitol Res; 2005 Apr; 96(1):49-56. PubMed ID: 15772867
[TBL] [Abstract][Full Text] [Related]
70. Overexpression and increased DNA topoisomerase II-like enzyme activity in arsenite resistant Leishmania donovani.
Jayanarayan KG; Dey CS
Microbiol Res; 2003; 158(1):55-8. PubMed ID: 12608580
[TBL] [Abstract][Full Text] [Related]
71. The kinetoplastid membrane protein 11 of Leishmania donovani and African trypanosomes is a potent stimulator of T-lymphocyte proliferation.
Tolson DL; Jardim A; Schnur LF; Stebeck C; Tuckey C; Beecroft RP; Teh HS; Olafson RW; Pearson TW
Infect Immun; 1994 Nov; 62(11):4893-9. PubMed ID: 7927770
[TBL] [Abstract][Full Text] [Related]
72. Biochemical and inhibition studies of glutamine synthetase from Leishmania donovani.
Kumar V; Yadav S; Soumya N; Kumar R; Babu NK; Singh S
Microb Pathog; 2017 Jun; 107():164-174. PubMed ID: 28351708
[TBL] [Abstract][Full Text] [Related]
73. Discovery of an Allosteric Binding Site in Kinetoplastid Methionyl-tRNA Synthetase.
Torrie LS; Robinson DA; Thomas MG; Hobrath JV; Shepherd SM; Post JM; Ko EJ; Ferreira RA; Mackenzie CJ; Wrobel K; Edwards DP; Gilbert IH; Gray DW; Fairlamb AH; De Rycker M
ACS Infect Dis; 2020 May; 6(5):1044-1057. PubMed ID: 32275825
[TBL] [Abstract][Full Text] [Related]
74. Leishmania donovani Exploits Tunneling Nanotubes for Dissemination and Propagation of B Cell Activation.
Stögerer T; Silva-Barrios S; Carmona-Pérez L; Swaminathan S; Mai LT; Leroux LP; Jaramillo M; Descoteaux A; Stäger S
Microbiol Spectr; 2023 Aug; 11(4):e0509622. PubMed ID: 37404188
[TBL] [Abstract][Full Text] [Related]
75. Tissue Specific Dual RNA-Seq Defines Host-Parasite Interplay in Murine Visceral Leishmaniasis Caused by Leishmania donovani and Leishmania infantum.
Forrester S; Goundry A; Dias BT; Leal-Calvo T; Moraes MO; Kaye PM; Mottram JC; Lima APCA
Microbiol Spectr; 2022 Apr; 10(2):e0067922. PubMed ID: 35384718
[TBL] [Abstract][Full Text] [Related]
76. CRISPR-Cas9-Mediated Genome Editing in Leishmania donovani.
Zhang WW; Matlashewski G
mBio; 2015 Jul; 6(4):e00861. PubMed ID: 26199327
[TBL] [Abstract][Full Text] [Related]
77. The structure of the transition state of the heterodimeric topoisomerase I of Leishmania donovani as a vanadate complex with nicked DNA.
Davies DR; Mushtaq A; Interthal H; Champoux JJ; Hol WG
J Mol Biol; 2006 Apr; 357(4):1202-10. PubMed ID: 16487540
[TBL] [Abstract][Full Text] [Related]
78. Mode of action of pentavalent antimonials: specific inhibition of type I DNA topoisomerase of Leishmania donovani.
Chakraborty AK; Majumder HK
Biochem Biophys Res Commun; 1988 Apr; 152(2):605-11. PubMed ID: 2835038
[TBL] [Abstract][Full Text] [Related]
79. Withdrawn: Variations in Altered Global Gene Expression caused by Topoisomerase II Poisons Assessed with Reference to Differences in DNA Binding.
Zihlif M; Catchpoole DR; Stewart BW; Wakelin LPG
Curr Mol Pharmacol; 2022 Mar; ():. PubMed ID: 35232357
[TBL] [Abstract][Full Text] [Related]
80. Structural insights on the small subunit of DNA topoisomerase I from the unicellular parasite Leishmania donovani.
Díaz González R; Pérez Pertejo Y; Redondo CM; Pommier Y; Balaña-Fouce R; Reguera RM
Biochimie; 2007 Dec; 89(12):1517-27. PubMed ID: 17900785
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
